Sara Shinnick

Sara Shinnick is a highly experienced medical professional with a strong focus on oncology and hematology. Currently serving as a Senior Field Medical Liaison for Geron Corporation since March 2023, Sara supports heme malignancy launch activities for Imetelstat. Prior roles include positions as Senior Medical Science Liaison at MorphoSys, supporting Tafasitamab and Pelabresib, and at AstraZeneca, focusing on Acalabrutinib and Moxetumomab. Sara has also held various leadership and liaison roles in medical affairs across multiple organizations, including managing regional teams and supporting significant oncology treatments such as Ibrutinib and Sorafenib. Beginning as a Nurse Practitioner in oncology at Children's Healthcare of Atlanta and Cincinnati Children's Hospital, Sara's educational background includes a Doctor of Nursing Practice from Brenau University, a Master of Science in Nursing from the University of Cincinnati, and a Bachelor of Science in Nursing from the same institution.